Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 10/20 | 0.44 |
| ▸ | KCNE1 | P15382 | 3/20 | 0.42 |
| ▸ | KCNQ1 | P51787 | 3/20 | 0.42 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2883832 | 1.00 | KCNA5 (0.44) | KCNA5KCNE1KCNQ1ABCB1ALDH1A1 | |
| SCHEMBL2891793 | 0.89 | ABCB1 (0.45) | KCNA5KCNE1KCNQ1ABCB1 | |
| SCHEMBL2898637 | 0.89 | ABCB1 (0.45) | KCNA5KCNE1KCNQ1ABCB1 | |
| SCHEMBL2891797 | 0.89 | ABCB1 (0.45) | KCNA5KCNE1KCNQ1ABCB1 | |
| SCHEMBL2891258 | 0.85 | KCNE1 (0.39) | KCNA5KCNE1KCNQ1CYP19A1 | |
| SCHEMBL2889416 | 0.85 | KCNA5 (0.47) | KCNA5KCNE1KCNQ1ABCB1ALDH1A1 | |
| SCHEMBL2889419 | 0.85 | KCNA5 (0.47) | KCNA5KCNE1KCNQ1ABCB1ALDH1A1 | |
| SCHEMBL2891256 | 0.84 | ALDH1A1 (0.42) | KCNA5KCNE1KCNQ1ALDH1A1HTT | |
| SCHEMBL2891650 | 0.82 | KCNA5 (0.45) | KCNA5KCNE1KCNQ1ABCB1 | |
| Hydrochloric Acid SCHEMBL2889246 | 0.81 | KCNA5 (0.45) | KCNA5KCNE1KCNQ1ABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1718629-B1 | Benzopyran compounds useful for the treatment of arrhytmia | NISSAN CHEMICAL IND LTD (JP) | 2012-12-26 | — | — | EP | claimed |
| US-20070299130-A1 | Benzopyran Compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-12-27 | — | — | US | claimed |
| US-7781483-B2 | Benzopyran compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-08-24 | — | — | US | disclosed |
| US-20070299130-A1 | Benzopyran Compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070299130-A1 | Benzopyran Compound | NR0B1, CYP2B6, RYR2 | KCNA5 69/4885KCNE1 166/4885KCNQ1 565/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.